BioPhase Solutions

We’ve all heard that AI will revolutionize medicine, but where are the results?

While no AI-designed drugs have reached the market yet, companies like Recursion and Insilico are inching closer with multiple candidates now in clinical trials.
Could 2025 finally be the year AI makes its mark in biotech?

Explore the debate on WIRED: https://www.wired.com/story/artificial-intelligence-drug-discovery/

Where Are All the AI Drugs? In an industry where 90 percent of drug candidates fail before reaching the market, a handful of startups are betting everything on AI to beat the odds.